Google Health’s Post

𝐓𝐡𝐚𝐧𝐤 𝐆𝐨𝐝 𝐈𝐭’𝐬 𝐃𝐫𝐀𝐢𝐝™ 𝐂𝐨𝐩𝐢𝐥𝐨𝐭 #4  Exciting News Alert: DrAid™ is on the verge of unveiling its tailored Tuberculosis Screening Solution for children! This week, DrAid™ Copilot will reveal an exciting new breakthrough in community tuberculosis screening, that is DrAid for TB Screening for children version, boasting an impressive sensitivity of up to 90.76% and specificity of 89.45%. This is also one of the rare AI products in the world that can serve children from 3 to 15 years old. Screening for tuberculosis in children remains a significant challenge, with this age group often overlooked in traditional testing methods, leading to misinterpretation of chest X-ray results. This development marks a pivotal milestone in the responsible application of AI for societal benefit, contributing to the promotion of Environmental, Social, and Governance (ESG) values on a global scale. 

Warsaw University of Technology joins international consortium PvSTATEM to combat malaria with AI #AI #artificialintelligence #diagnostictest #digitaltechnologies #globalpartners #Healthcare #hypnozoites #llm #machinelearning #malaria #malariaeradication #malariasurveillance #malariatransmission #mathematicalmodeling #mobilehealthtech #Plasmodiumvivax #predictivesoftware #primaquinetreatment #PvSeroTAT #PvSTATEMconsortium #WarsawUniversityofTechnology

Don't Be Fooled: TB is Still a Global Threat. But Innovation is Fighting Back, with Value in Mind! Tuberculosis (TB) hasn't vanished, but the fight against it is getting a major boost thanks to cutting-edge technology and innovative financing strategies. However, ensuring these advancements deliver maximum value requires a strategic approach. Why We Need to Stay Vigilant: -Missed Diagnoses: Up to 50% of TB cases lack classic symptoms, making early detection crucial. -Limited Resources: Traditional methods often require expensive equipment and specialists, hindering access in remote areas. The Fight Back - Innovation with Value: -AI-powered X-rays: This exciting technology can analyze chest X-rays, potentially identifying TB cases quickly and efficiently. (VBHC): Integrating AI tools within healthcare delivery systems can optimize resource allocation and improve patient outcomes. -Portable X-ray machines with AI: Perfect for remote locations, these tools allow for on-the-spot screening and faster diagnosis. (HTA): Health Technology Assessments (HTA) can ensure these portable solutions are cost-effective and deliver value compared to traditional methods. - Affordable drug-resistance testing: Truenat, a cheaper and battery-powered alternative to traditional tests, helps detect drug-resistant TB efficiently. (VBHC & HTA): Cost-effective testing allows for broader screening and earlier intervention, ultimately reducing healthcare costs. -Shorter, more effective treatments: The new BPaLM regimen offers a six-month, all-oral approach for drug-resistant TB, improving patient outcomes and reducing treatment burden. (VBHC & HTA): Both Value-Based Healthcare (VBHC) and HTA principles can be applied to assess the cost-effectiveness and overall value of this new treatment regimen for healthcare systems. The Call to Action: -Investment in R&D: Continued research is crucial to develop even more powerful tools for TB diagnosis and treatment. -Global Collaboration: Sharing knowledge and resources across borders is vital to ensure everyone has access to these advancements. -Value-Driven Implementation: Utilizing frameworks like VBHC and HTA can ensure these innovations deliver optimal value for patients and healthcare systems. Let's celebrate the progress, but remember, the fight against TB isn't over. By embracing innovation guided by value, we can turn the tide on this global health challenge. #TB #HealthcareInnovation #GlobalHealth #AI #PublicHealth #VBHC #HTA #HealthPolicy

Imagine the possibilities with cell-specific recognition or "active targeting"! With the power of AI at hand, Kahina Lang dives into a revolutionary quest to do what has never been done - cure 'incurable' diseases. See how she's shaking up the scene with mRNA. #mRNA #LNP #drugdiscovery

Looking forward to this great panel including my colleague, AI expert Hamza Ghadyali, at BIO 2023. Understanding how pandemic viruses turn our immune systems into our own worst enemies is critical to develop new therapeutic strategies. Join our panel discussion at #bio2023 to learn how #AI and #ML tools are being deployed in the fight against ever-evolving viral pathogens. http://2.sas.com/6040OsihG

https://lnkd.in/gD87yZEd While the world races to find solutions for emerging and longstanding diseases, a significant portion of the global population remains underrepresented in #genetic studies.    #CDOTrends #digitaltransformation #digitalstrategy #aitrends #genomes

The application of artificial intelligence (AI) to combating infectious diseases is seeing exciting advancements. A recent Science article highlights how AI is turbocharging anti-infective drug discovery, unraveling the biology of infection, and accelerating diagnostic development. Despite progress in science, infectious diseases remain a formidable public health challenge. Overcoming this requires interdisciplinary efforts with AI at the core. AI expands the horizons of anti-infective drug discovery, elucidates infection biology, and speeds up diagnostic advancement. The article foreshadows future AI applications for controlling outbreaks and pandemics. Combating infectious diseases is a global endeavor. It's promising to see AI become a potent weapon in this fight. #ai #InfectiousDiseases #PublicHealth #DrugDiscovery #Diagnostics #FutureOfHealthcare #HealthcareTomorrow

Today, on Rare Disease Day, we stand together to raise awareness and support for those facing uncommon challenges. At Fabric Genomics, we are dedicated to making a difference in the lives of individuals and families affected by rare diseases. Our commitment to advancing genomic solutions empowers clinicians and researchers in the quest for accurate diagnoses and personalized treatment options. By harnessing the power of Artificial Intelligence (AI), we strive to provide faster answers to all who are navigating the complexities of rare diseases. We are honored and proud to participate in this collective effort to drive innovation, collaboration, and understanding. Together, we can make strides towards a future where rare diseases are better understood and more effectively treated. Join us in recognizing the strength and resilience of the rare disease community. Let's please continue to make a lasting impact! 🤝 #RareDiseaseDay #Genomics #PrecisionMedicine #RareDiseases